RADCOM (RDCM) director David Ripstein reports initial share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
RADCOM LTD director David Ripstein filed an initial ownership report showing his equity position in the company. He holds 13,590 Ordinary Shares directly and share options covering 16,000 Ordinary Shares with a $10.01 exercise price expiring on October 15, 2034. The options were granted on October 15, 2024 and vest monthly from November 15, 2024 through October 15, 2026. The filing also notes 3,500 additional Ordinary Shares issuable as restricted share units that vest monthly until October 15, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Ripstein David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Options (right to buy) — 16,000 shares (Direct);
Ordinary Shares — 13,590 shares (Direct)
Footnotes (1)
- Includes a total amount of 3,500 Ordinary Shares issuable upon the vesting of restricted share units on a monthly basis until October 15, 2026. The options were granted on October 15, 2024, and vest on a monthly basis, beginning November 15, 2024, until October 15, 2026.
FAQ
What does the Form 3 filing by David Ripstein for RADCOM (RDCM) show?
The Form 3 shows director David Ripstein’s initial ownership in RADCOM. He reports 13,590 Ordinary Shares held directly, plus share options for 16,000 Ordinary Shares and 3,500 additional shares issuable through restricted share units that vest monthly through October 15, 2026.
Is David Ripstein’s Form 3 for RADCOM (RDCM) a buy or sell transaction?
The Form 3 is an initial ownership report, not a buy or sell transaction. It lists Ripstein’s existing holdings in Ordinary Shares, share options, and restricted share units as of the reporting date, without disclosing any new purchases or sales of RADCOM securities.